Georgia vs Syria: The number of people with susceptibility test result for rifampicin
Georgia
953
in 2021
Syria
705
in 2021
Georgia rank
68th
Syria rank
71st
The number of people with susceptibility test result for rifampicin over time
- Georgia
- Syria
How they compare
Georgia currently reports 953 against 705 in Syria, a difference of 248.
That makes Georgia's figure about 1.4 times Syria's.
Across all 5 years both countries report, Georgia has been ahead every year.
Georgia ranks 68th and Syria ranks 71st of 155 countries.
Georgia has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Georgia | Syria | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 1,372 | 491.33 | 880.33 | Georgia |
| 2020s | 1,008 | 808.5 | 200 | Georgia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Georgia or Syria?
- Georgia, at 953 against 705 in Syria as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Georgia and Syria?
- 248, with Georgia ahead.
- How many years of comparable data are there for Georgia and Syria?
- 5 years are reported by both, from 2017 to 2021.
- How do Georgia and Syria rank globally for the number of people with susceptibility test result for rifampicin?
- Georgia ranks 68th and Syria ranks 71st of 155 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid refreshes it automatically from the source and publishes the full history for both places.